Subscribe to RSS
DOI: 10.1055/s-0030-1249066
© Georg Thieme Verlag KG Stuttgart · New York
Compound Heterozygosity of the Protein S-Gene as a Cause of Severe Cerebral Sinovenous Thrombosis in a 7-Year-Old Child
Compound-heterozygote Mutationen des Protein-S-Gens als Ursache für eine Sinusvenenthrombose bei einem 7-jährigen MädchenPublication History
Publication Date:
31 May 2010 (online)
Abstract
The genotype-phenotype relationship of compound heterozygous protein S-deficiency in a 7-year-old girl with reduced protein S-levels and a severe cerebral sinovenous thrombosis is illustrated. In this patient we identified a novel deletion in the protein S-gene causing a compound heterozygous state and subsequently a symptomatic protein S-deficiency. In case of thrombosis analysis of protein S is recommended. Low levels of protein S should be further investigated by molecular diagnostics.
Zusammenfassung
Dieser Artikel charakterisiert das Verhältnis von Genotyp zu Phänotyp bei Compound-heterozygotem Protein-S-Mangel bei einem Mädchen mit schwerer Sinusvenenthrombose und Protein-S-Mangel. Wir wiesen eine bisher unbekannte Deletion im Protein-S-Gen nach, die zu einer Compound-Heterozygotie und somit zu einem symptomatischen Protein-S-Mangel führte. Im Falle einer Thrombose wird die Bestimmung von Protein S empfohlen; wiederholt niedrige Werte für Protein S können molekulargenetisch abgeklärt werden.
Key words
sinovenous thrombosis - protein S-deficiency - thrombophilia - compound heterozygous mutations - missense mutation - deletion
Schlüsselwörter
Sinusvenenthrombose - Protein S-Mangel - Thrombophilie - Compound-heterozygote Mutationen - Missense-Mutation - Deletion
References
- 1 Bernbeck B, Wüller D, Janssen G. et al . Symptoms of childhood acute lymphoblastic leukemia: red flags to recognize leukemia in daily practice. Klin Pädiatr. 2009; 221 369-373
- 2 Duchemin J, Gandrille S, Borgel D. et al . The Ser 460 to Pro substitution of the protein S alpha (PROS1) gene is a frequent mutation associated with free protein S (type IIa) deficiency. Blood. 1995; 86 3436-3443
- 3 Ege MJ, Meyer LH, Debatin KM. et al . Coincidence of recurrent hemiparesis and detection of ALL in a 4-year-old girl: one or two diseases?. Klin Pädiatr. 2009; 221 386-389
- 4 Heller C, Heinecke A, Junker R. et al . Cerebral venous thrombosis in children: A multifactorial origin. Circulation. 2003; 108 1362-1367
- 5 Kenet G, Kirkham F, Niederstadt T. et al . Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol. 2007; 6 595-603
- 6 Monagle P, Chan A, Massicotte P. et al . Antithrombotic therapy in children: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004; 126 645-687
- 7 Nowak-Göttl U, Junker R, Kreuz W. et al . Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood. 2001; 97 858-862
- 8 Nowak-Göttl U, Kurnik K, Krümpel A. et al . Thrombophilia in the young. Hamostaseologie. 2008; 28 16-20
Correspondence
Dr. Ina Hainmann
University Medical Center Freiburg
Department of Paediatrics and Adolescent Medicine
Mathildenstraße 1
79106 Freiburg
Germany
Phone: +49/761/270 4300
Fax: +49/761/270 4616
Email: ina.hainmann@uniklinik-freiburg.de